Literature DB >> 10342905

Interaction between rifampin and levothyroxine.

S R Nolan1, T H Self, J M Norwood.   

Abstract

Rifampin is a potent inducer of hepatic enzymes and is well documented to cause many clinically significant drug interactions. Studies in normal volunteers have shown its ability to decrease circulating levels of thyroid hormone, while having no effect on thyroid-stimulating hormone (TSH). Reports of rifampin's effects on patients on hormone replacement in the clinical setting are of interest since we believe only one such case has been described. We report the case of a man, stable on levothyroxine, who exhibited significantly elevated TSH levels during therapy with rifampin. Thyroid-stimulating hormone levels returned to baseline 9 days after discontinuance of rifampin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342905     DOI: 10.1097/00007611-199905000-00018

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

Review 1.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.

Authors:  Peter Laurberg; Stig Andersen; Inge Bülow Pedersen; Allan Carlé
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Rifampin-induced hypothyroidism.

Authors:  N Takasu; Y Kinjou; T Kouki; M Takara; Y Ohshiro; I Komiya
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

5.  Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication.

Authors:  Hye In Kim; Tae Hyuk Kim; Hosu Kim; Young Nam Kim; Hye Won Jang; Jae Hoon Chung; Seong Mi Moon; Byung Woo Jhun; Hyun Lee; Won-Jung Koh; Sun Wook Kim
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

6.  Pituitary hyperplasia: a complication of the pseudomalabsorption of thyroxine.

Authors:  Mary-Anne Doyle; Heather A Lochnan
Journal:  Int J Gen Med       Date:  2013-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.